Table 1a:
Cohort characteristics (by patient)
| Variable | Median (IQR) (Total N=2059) | No CIED Infection (N = 1960) | CIED infection (N = 99) | P-value |
|---|---|---|---|---|
| Demographics | ||||
| Age | 71.7 (64.4–81.0) | 71.8 (64.5–81.1) | 68.6 (62.2–79.6) | 0.078 |
| Sex | 2,015 (97.9%) | 1,918 (97.9%) | 97 (98.0%) | 1 |
| Race | ||||
| White | 1,778 (86.4%) | 1,688 (86.1%) | 90 (90.9%) | 0.25 |
| Black | 245 (11.9%) | 236 (12.0%) | 9 (9.1%) | |
| Other | 36 (1.7%) | 36 (1.8%) | 0 (0.0%) | |
| Hispanic Ethnicity | 146 (7.1%) | 138 (7.0%) | 8 (8.1%) | 0.69 |
| Co-morbidities | ||||
| Elixhauser Risk Score (Median (IQR)) | 6.0 (4.0–8.0) | 6.0 (4.0–8.0) | 6.0 (5.0–8.0) | 0.13 |
| BMI (Median (IQR)) | 28.3 (25.0–32.7) | 28.3 (25.1–32.8) | 27.7 (24.4–32.6) | 0.55 |
| Diabetes | 970 (47.1%) | 921 (47.0%) | 49 (49.5%) | 0.63 |
| Tobacco Use | 1,036 (50.3%) | 982 (50.1%) | 54 (54.5%) | 0.39 |
| Chronic Obstructive Pulmonary Disease | 628 (30.5%) | 590 (30.1%) | 38 (38.4%) | 0.081 |
| Cerebrovascular Disease | 480 (23.3%) | 449 (22.9%) | 31 (31.3%) | 0.054 |
| Peripheral Arterial Disease | 470 (22.8%) | 432 (22.0%) | 38 (38.4%) | 0.0002 |
| Chronic Kidney Disease | 670 (32.5%) | 638 (32.6%) | 32 (32.3%) | 0.96 |
| Dialysis | 66 (3.2%) | 62 (3.2%) | 4 (4.0%) | 0.56 |
| Beta-Lactam Allergy | 300 (14.6%) | 287 (14.6%) | 13 (13.1%) | 0.68 |
| MRSA pre-procedure | 13 (0.6%) | 10 (0.5%) | 3 (3.0%) | 0.022 |